Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$598K Sell
40,900
-14,300
-26% -$210K ﹤0.01% 3759
2025
Q4
$698K Buy
55,200
+8,000
+17% +$118K ﹤0.01% 3753
2025
Q3
$726K Buy
47,200
+34,000
+258% +$548K ﹤0.01% 3656
2025
Q2
$208K Buy
+13,200
New +$200K ﹤0.01% 4041
2023
Q1
Sell
-38,700
Closed -$666K 4803
2022
Q4
$666K Buy
+38,700
New +$686K ﹤0.01% 3700

Other funds holding RXO

D.E. Shaw & Co's RXO Position: Q1 2025 in Review

D.E. Shaw & Co sold out of RXO (RXO) in Q1 2025, closing a stake of 38,261 shares — an estimated $912K sold.

D.E. Shaw & Co first reported a position in RXO in Q3 2023 and held it in 6 quarters. The position peaked at $2.99M in Q4 2023. 257 funds tracked by Wall St. Rank hold RXO as of Q1 2025.

  • D.E. Shaw & Co reported no remaining RXO position as of Q1 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 38,261 RXO shares in Q1 2025, an estimated $912K.
  • D.E. Shaw & Co first reported a position in RXO in Q3 2023 and held it in 6 quarters.
  • D.E. Shaw & Co's RXO position peaked at $2.99M in Q4 2023.
  • 257 funds tracked by Wall St. Rank held RXO as of Q1 2025.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.